Go Pro

AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$31.14 -1.66 (-5.06%)
As of 02:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AMN vs. EYE, MEDP, VEEV, WST, and RDNT

Should you buy AMN Healthcare Services stock or one of its competitors? MarketBeat compares AMN Healthcare Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AMN Healthcare Services include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and RadNet (RDNT).

How does AMN Healthcare Services compare to National Vision?

National Vision (NASDAQ:EYE) and AMN Healthcare Services (NYSE:AMN) are related small-cap companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

99.2% of AMN Healthcare Services shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

National Vision has a net margin of 2.31% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
AMN Healthcare Services -0.95%18.01%5.19%

National Vision presently has a consensus price target of $30.08, indicating a potential upside of 32.00%. AMN Healthcare Services has a consensus price target of $29.00, indicating a potential downside of 6.88%. Given National Vision's stronger consensus rating and higher possible upside, equities analysts clearly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

National Vision has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.92$29.60M$0.5739.98
AMN Healthcare Services$2.73B0.44-$95.70M-$0.87N/A

National Vision has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

In the previous week, National Vision and National Vision both had 4 articles in the media. National Vision's average media sentiment score of 1.10 beat AMN Healthcare Services' score of 0.89 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

National Vision beats AMN Healthcare Services on 11 of the 15 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

AMN Healthcare Services (NYSE:AMN) and Medpace (NASDAQ:MEDP) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market.

Medpace has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.44-$95.70M-$0.87N/A
Medpace$2.53B6.42$451.12M$17.0634.10

In the previous week, Medpace had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 12 mentions for Medpace and 4 mentions for AMN Healthcare Services. Medpace's average media sentiment score of 1.23 beat AMN Healthcare Services' score of 0.89 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
10 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AMN Healthcare Services currently has a consensus price target of $29.00, indicating a potential downside of 6.88%. Medpace has a consensus price target of $584.18, indicating a potential upside of 0.41%. Given Medpace's higher possible upside, analysts clearly believe Medpace is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
Medpace
0 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.15

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 20.5% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Medpace has a net margin of 17.67% compared to AMN Healthcare Services' net margin of -0.95%. Medpace's return on equity of 110.15% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-0.95% 18.01% 5.19%
Medpace 17.67%110.15%24.84%

Summary

Medpace beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

Veeva Systems (NYSE:VEEV) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Veeva Systems had 20 more articles in the media than AMN Healthcare Services. MarketBeat recorded 24 mentions for Veeva Systems and 4 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 1.08 beat AMN Healthcare Services' score of 0.89 indicating that Veeva Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veeva Systems
14 Very Positive mention(s)
5 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Veeva Systems presently has a consensus price target of $247.08, suggesting a potential upside of 14.81%. AMN Healthcare Services has a consensus price target of $29.00, suggesting a potential downside of 6.88%. Given Veeva Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veeva Systems
1 Sell rating(s)
8 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
2.68
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

88.2% of Veeva Systems shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 10.6% of Veeva Systems shares are owned by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veeva Systems$3.20B10.94$908.91M$5.6138.36
AMN Healthcare Services$2.73B0.44-$95.70M-$0.87N/A

Veeva Systems has a net margin of 28.37% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Veeva Systems28.37% 13.72% 11.31%
AMN Healthcare Services -0.95%18.01%5.19%

Veeva Systems has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

Summary

Veeva Systems beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

AMN Healthcare Services (NYSE:AMN) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

West Pharmaceutical Services has a net margin of 16.98% compared to AMN Healthcare Services' net margin of -0.95%. West Pharmaceutical Services' return on equity of 20.11% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-0.95% 18.01% 5.19%
West Pharmaceutical Services 16.98%20.11%14.83%

AMN Healthcare Services has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

AMN Healthcare Services currently has a consensus price target of $29.00, suggesting a potential downside of 6.88%. West Pharmaceutical Services has a consensus price target of $368.08, suggesting a potential upside of 5.85%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
3.00

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.44-$95.70M-$0.87N/A
West Pharmaceutical Services$3.33B7.36$493.70M$7.8144.52

In the previous week, West Pharmaceutical Services had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 12 mentions for West Pharmaceutical Services and 4 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 1.58 beat AMN Healthcare Services' score of 0.89 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
11 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does AMN Healthcare Services compare to RadNet?

RadNet (NASDAQ:RDNT) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

In the previous week, RadNet had 1 more articles in the media than AMN Healthcare Services. MarketBeat recorded 5 mentions for RadNet and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.89 beat RadNet's score of 0.86 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

77.9% of RadNet shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

RadNet has higher earnings, but lower revenue than AMN Healthcare Services. RadNet is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.59-$18.65M-$0.18N/A
AMN Healthcare Services$2.73B0.44-$95.70M-$0.87N/A

RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

RadNet presently has a consensus target price of $87.43, suggesting a potential upside of 30.10%. AMN Healthcare Services has a consensus target price of $29.00, suggesting a potential downside of 6.88%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

RadNet has a net margin of -0.66% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.66% 2.77% 0.97%
AMN Healthcare Services -0.95%18.01%5.19%

Summary

RadNet beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.21B$9.81B$6.90B$24.04B
Dividend YieldN/A2.56%2.60%3.70%
P/E Ratio-35.8025.25281.4032.00
Price / Sales0.445.40571.91165.52
Price / Cash4.01125.0671.7932.36
Price / Book1.865.1812.866.88
Net Income-$95.70M$312.25M$3.49B$1.07B
7 Day Performance-10.65%0.03%2.49%1.88%
1 Month Performance-13.11%-2.31%-2.82%1.47%
1 Year Performance80.87%24.00%75.72%19.41%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
1.8427 of 5 stars
$31.14
-5.1%
$29.00
-6.9%
+87.2%$1.21B$2.73BN/A2,664
EYE
National Vision
4.3732 of 5 stars
$22.42
+1.7%
$30.08
+34.2%
-7.2%$1.77B$1.99B39.3313,138
MEDP
Medpace
2.8959 of 5 stars
$573.29
-0.7%
$584.18
+1.9%
+34.7%$16.11B$2.53B33.606,200
VEEV
Veeva Systems
4.3638 of 5 stars
$206.11
+1.1%
$247.08
+19.9%
-24.2%$33.10B$3.32B36.747,928
WST
West Pharmaceutical Services
4.0152 of 5 stars
$347.76
+2.0%
$368.08
+5.8%
+46.7%$24.00B$3.07B44.5310,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners